Stock Price Quote

SHUKRA PHARMACEUTICALS LTD.

NSE : NABSE : 524632ISIN CODE : INE551C01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE262.9012.5 (+4.99 %)
PREV CLOSE ( ) 250.40
OPEN PRICE ( ) 262.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7976
TODAY'S LOW / HIGH ( )262.90 262.90
52 WK LOW / HIGH ( ) 41.76250.4
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-03 1993
Management Info
Dakshesh Shah - Chairman Dakshesh Shah - Managing Director
Registered Office

Address 3rd Floor, Veer House,Opp Wiaa Office ,Judges Bunglow Road Bodakdev,
Ahmedabad,
Gujarat-380054

Phone 079-27498515

Email info@shukrapharmaceuticals.com

Website www.shukrapharmaceuticals.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, Ahmedabad

NEWS

23Feb Allotment of Equity Shares
Increase in Authorised Capital & Bonus issue Inter alia, to consider an..
23Feb Bonus Announcement
Increase in Authorised Capital & Bonus issue Inter alia, to consider an..
19Dec Conversion Of Partly Paid-Up Equity S
Conversion of partly paid-up equity shares to fully paid-up equity shares.
18Dec Announcement Under Regulation 30 (LOD
Forfeiture of 12739 partly paid-up equity shares on which first and/or s..
28Nov Appointment of Director
Inter alia considered and approved the following matters: L. Appointmen..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit94.244.0599999999999
Gross Profit 95.28 44.4099999999999
Operating Profit 101.0665.5999999999999
Net Sales 188.91588.34

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  28639.35 (0.55%)
M.Cap ( in Cr)60856.62
Bharat Parenterals (BSE)
peergroup  1147.65 (10.28%)
M.Cap ( in Cr)667.89
Astrazeneca Pharma I (BSE)
peergroup  5567.65 (1.95%)
M.Cap ( in Cr)13919.13
Neuland Laboratories (BSE)
peergroup  7063.75 (1.37%)
M.Cap ( in Cr)9062.71
Mankind Pharma (BSE)
peergroup  2097.55 (1.58%)
M.Cap ( in Cr)84025.43

Shareholding Pattern

PROMOTERS 50.96%
NON-INSTITUTION 48.93%
FI/BANKS/INSURANCE 0.11%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd. was incorporated in the year 1993. Its today's share price is 262.9. Its current market capitalisation stands at Rs 287.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 588.34 Cr and Total Income of Rs.600.3 Cr. The company's management includes Pinki Nirmal Sagar, Arpita Kabraa, Bhoomiben Patel, Sanskruti Patel, Dhruvin Shah, Payal Mehta, Sarjeevan Rathore, Sonal Gandhi, Dakshesh Shah, Dakshesh Shah.

It is listed on the BSE with a BSE Code of 524632 , NSE with an NSE Symbol of and ISIN of INE551C01028. It's Registered office is at 3rd Floor, Veer House,Opp Wiaa Office ,Judges Bunglow Road BodakdevAhmedabad-380054, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BJ Trivedi & Associates, MAAK & Associates, Rajesh Singi & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.